Skip to main content
Top
Published in: BMC Nephrology 1/2015

Open Access 01-12-2015 | Research article

Variability in monthly serum bicarbonate measures in hemodialysis patients: a cohort study

Authors: Ravi Patel, William Paredes, Charles B. Hall, Mark A. Nader, Deepak Sapkota, Vaughn W. Folkert, Matthew K. Abramowitz

Published in: BMC Nephrology | Issue 1/2015

Login to get access

Abstract

Background

Some nephrologists have advocated an individualized approach to the prescription of bicarbonate hemodialysis. However, the utility of monthly serum bicarbonate levels for guiding and evaluating such treatment decisions has not been evaluated. We sought to define the variability of these measurements and to determine factors that are associated with month-to-month variability in pre-dialysis serum bicarbonate.

Methods

We examined the monthly variability in serum bicarbonate measurements among 181 hemodialysis patients admitted to a free-standing dialysis unit in the Bronx, NY from 1/1/2008-6/30/2012. All patients were treated with a uniform bicarbonate dialysis prescription (bicarbonate 35 mEq/L, acetate 8 mEq/L). Pre-dialysis serum bicarbonate values were obtained from monthly laboratory reports. Month-to-month variability was defined using a rolling measurement for each time point.

Results

Only 34 % of high serum bicarbonate values (>26 mEq/L) remained high in the subsequent month, whereas 60 % converted to normal (22–26 mEq/L). Of all low values (<22 mEq/L), 41 % were normal the following month, while 58 % remained low. Using the mean 3-month bicarbonate, only 29 % of high values remained high in the next 3-month period. In multivariable-adjusted longitudinal models, both low and high serum bicarbonate values were associated with greater variability than were normal values (β = 0.12 (95 % CI 0.09–0.15) and 0.24 (0.18 to 0.29) respectively). Variability decreased with time, and was significantly associated with age, phosphate binder use, serum creatinine, potassium, and normalized protein catabolic rate.

Conclusions

Monthly pre-dialysis serum bicarbonate levels are highly variable. Even if a clinician takes no action, approximately 50 % of bicarbonate values outside a normal range of 22–26 mEq/L will return to normal in the subsequent month. The decision to change the bicarbonate dialysis prescription should not be based on a single bicarbonate value, and even a 3-month mean may be insufficient.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(4):661–71.PubMedCrossRef Bommer J, Locatelli F, Satayathum S, Keen ML, Goodkin DA, Saito A, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44(4):661–71.PubMedCrossRef
2.
go back to reference Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol. 2006;1(1):70–8.PubMedCrossRef Wu DY, Shinaberger CS, Regidor DL, McAllister CJ, Kopple JD, Kalantar-Zadeh K. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic? Clin J Am Soc Nephrol. 2006;1(1):70–8.PubMedCrossRef
3.
go back to reference Kraut JA, Nagami GT. The use and interpretation of serum bicarbonate concentration in dialysis patients. Semin Dial. 2014;27(6):577–9.PubMedCrossRef Kraut JA, Nagami GT. The use and interpretation of serum bicarbonate concentration in dialysis patients. Semin Dial. 2014;27(6):577–9.PubMedCrossRef
4.
go back to reference K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-266. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002, 39(2 Suppl 1):S1-266.
5.
go back to reference Heineken FG, Brady-Smith M, Haynie J, Van Stone JC. Prescribing dialysate bicarbonate concentrations for hemodialysis patients. Int J Artif Organs. 1988;11(1):45–50.PubMed Heineken FG, Brady-Smith M, Haynie J, Van Stone JC. Prescribing dialysate bicarbonate concentrations for hemodialysis patients. Int J Artif Organs. 1988;11(1):45–50.PubMed
6.
go back to reference Saikumar JH, Kovesdy CP. Bicarbonate therapy in end-stage renal disease: current practice trends and implications. Semin Dial. 2015;28(4):370–6.PubMedCrossRef Saikumar JH, Kovesdy CP. Bicarbonate therapy in end-stage renal disease: current practice trends and implications. Semin Dial. 2015;28(4):370–6.PubMedCrossRef
7.
go back to reference Chen JL, Kalantar-Zadeh K. Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial. 2014;27(3):259–62.PubMedPubMedCentralCrossRef Chen JL, Kalantar-Zadeh K. Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial. 2014;27(3):259–62.PubMedPubMedCentralCrossRef
9.
go back to reference Hood VL, Tannen RL. Protection of acid-base balance by pH regulation of acid production. N Engl J Med. 1998;339(12):819–26.PubMedCrossRef Hood VL, Tannen RL. Protection of acid-base balance by pH regulation of acid production. N Engl J Med. 1998;339(12):819–26.PubMedCrossRef
10.
go back to reference Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torlen K, Mehrotra R. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol. 2013;8(2):254–64.PubMedPubMedCentralCrossRef Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torlen K, Mehrotra R. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol. 2013;8(2):254–64.PubMedPubMedCentralCrossRef
11.
go back to reference Lisawat P, Gennari FJ. Approach to the hemodialysis patient with an abnormal serum bicarbonate concentration. Am J Kidney Dis. 2014;64(1):151–5.PubMedCrossRef Lisawat P, Gennari FJ. Approach to the hemodialysis patient with an abnormal serum bicarbonate concentration. Am J Kidney Dis. 2014;64(1):151–5.PubMedCrossRef
12.
go back to reference Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–7.PubMedCrossRef Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17(6):432–7.PubMedCrossRef
13.
go back to reference Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.PubMedCrossRef Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.PubMedCrossRef
14.
go back to reference Tentori F, Karaboyas A, Robinson BM, Morgenstern H, Zhang J, Sen A, et al. Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2013;62(4):738–46.PubMedCrossRef Tentori F, Karaboyas A, Robinson BM, Morgenstern H, Zhang J, Sen A, et al. Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2013;62(4):738–46.PubMedCrossRef
15.
go back to reference Chauveau P, Fouque D, Combe C, Laville M, Canaud B, Azar R, et al. Acidosis and nutritional status in hemodialyzed patients. French Study Group for Nutrition in Dialysis. Semin Dial. 2000;13(4):241–6.PubMedCrossRef Chauveau P, Fouque D, Combe C, Laville M, Canaud B, Azar R, et al. Acidosis and nutritional status in hemodialyzed patients. French Study Group for Nutrition in Dialysis. Semin Dial. 2000;13(4):241–6.PubMedCrossRef
16.
go back to reference Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, et al. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis. 2003;42(6):1200–11.PubMedCrossRef Kaysen GA, Greene T, Daugirdas JT, Kimmel PL, Schulman GW, Toto RD, et al. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients. Am J Kidney Dis. 2003;42(6):1200–11.PubMedCrossRef
17.
go back to reference Uribarri J, Levin NW, Delmez J, Depner TA, Ornt D, Owen W, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis. 1999;34(3):493–9.PubMedCrossRef Uribarri J, Levin NW, Delmez J, Depner TA, Ornt D, Owen W, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis. 1999;34(3):493–9.PubMedCrossRef
18.
go back to reference Fan S, Ross C, Mitra S, Kalra P, Heaton J, Hunter J, et al. A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis. Nephrol Dial Transplant. 2009;24(12):3794–9.PubMedPubMedCentralCrossRef Fan S, Ross C, Mitra S, Kalra P, Heaton J, Hunter J, et al. A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis. Nephrol Dial Transplant. 2009;24(12):3794–9.PubMedPubMedCentralCrossRef
19.
go back to reference Filiopoulos V, Koutis I, Trompouki S, Hadjiyannakos D, Lazarou D, Vlassopoulos D. Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients. Ther Apher Dial. 2011;15(1):20–7.PubMedCrossRef Filiopoulos V, Koutis I, Trompouki S, Hadjiyannakos D, Lazarou D, Vlassopoulos D. Lanthanum carbonate versus sevelamer hydrochloride: improvement of metabolic acidosis and hyperkalemia in hemodialysis patients. Ther Apher Dial. 2011;15(1):20–7.PubMedCrossRef
20.
go back to reference Goldberg DI, Dillon MA, Slatopolsky EA, Garrett B, Gray JR, Marbury T, et al. Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients. Nephrol Dial Transplant. 1998;13(9):2303–10.PubMedCrossRef Goldberg DI, Dillon MA, Slatopolsky EA, Garrett B, Gray JR, Marbury T, et al. Effect of RenaGel, a non-absorbed, calcium- and aluminium-free phosphate binder, on serum phosphorus, calcium, and intact parathyroid hormone in end-stage renal disease patients. Nephrol Dial Transplant. 1998;13(9):2303–10.PubMedCrossRef
21.
go back to reference Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, et al. Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int. 2004;65(5):1914–26.PubMedCrossRef Qunibi WY, Hootkins RE, McDowell LL, Meyer MS, Simon M, Garza RO, et al. Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int. 2004;65(5):1914–26.PubMedCrossRef
22.
go back to reference Bray SH, Tung RL, Jones ER. The magnitude of metabolic acidosis is dependent on differences in bicarbonate assays. Am J Kidney Dis. 1996;28(5):700–3.PubMedCrossRef Bray SH, Tung RL, Jones ER. The magnitude of metabolic acidosis is dependent on differences in bicarbonate assays. Am J Kidney Dis. 1996;28(5):700–3.PubMedCrossRef
23.
go back to reference Kirschbaum B. Spurious metabolic acidosis in hemodialysis patients. Am J Kidney Dis. 2000;35(6):1068–71.PubMedCrossRef Kirschbaum B. Spurious metabolic acidosis in hemodialysis patients. Am J Kidney Dis. 2000;35(6):1068–71.PubMedCrossRef
25.
go back to reference Zazra JJ, Jani CM, Rosenblum S. Are the results of carbon dioxide analysis affected by shipping blood samples? Am J Kidney Dis. 2001;37(5):1105–6.PubMedCrossRef Zazra JJ, Jani CM, Rosenblum S. Are the results of carbon dioxide analysis affected by shipping blood samples? Am J Kidney Dis. 2001;37(5):1105–6.PubMedCrossRef
Metadata
Title
Variability in monthly serum bicarbonate measures in hemodialysis patients: a cohort study
Authors
Ravi Patel
William Paredes
Charles B. Hall
Mark A. Nader
Deepak Sapkota
Vaughn W. Folkert
Matthew K. Abramowitz
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2015
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-015-0206-2

Other articles of this Issue 1/2015

BMC Nephrology 1/2015 Go to the issue